Shitara K, Doi T, Dvorkin M, et al. Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2018; 19: 1437–48—In figure 3 in this Article, several datapoints were incorrectly plotted, and one value on the scale on the x-axis was incorrect. One value on the scale on the x-axis of appendix figure 1 was also incorrect. These issues and several other minor errors have been corrected as of Nov 28, 2018.
[Corrections] Correction to Lancet Oncol 2018; 19: 1437–48
Leggi l'articolo originale